We report two cases of metastatic liver carcinoma with the treatment of radiofrequency ablation (RFA) and intraarterial chemotherapy. The 57-year-old man of Case 1 had resectable multiple liver metastases of rectal carcinoma in November 2007. He refused a liver resection, but accepted a low anterior resection of the rectum and RFA and intraarterial chemotherapy (5-FU 1,000 mg WHD). After this treatment, he had accepted systemic chemotherapy and found no liver recurrence within a year. The 66-year-old man of Case 2 had unresectable multiple liver metastases of locally-advanced esophageal carcinoma in July 2006. He had accepted radiochemotherapy (FP+65 Gy), and then RFA and intraarterial chemotherapy (5-FU 1,000 mg WHD). After this treatment, solitary brain metastasis and lymph node metastasis of mediastinum were found and treated, and now he has been alive with systemic chemotherapy.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Interventional Treatment Strategies in Intrahepatic Cholangiocarcinoma and Perspectives for Combined Hepatocellular-Cholangiocarcinoma.
Cancers (Basel)
May 2023
Department of Radiology, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
cHCC-CCA is an uncommon type of liver cancer that exhibits clinical and pathological characteristics of both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA), which are the two main forms of primary liver cancer. The similarity to HCC and CCA makes therapeutical strategies challenging. The poor prognosis of CCA in general, as well as for cHCC-CCA, is mainly attributable to the fact that diagnosis is often at an advanced stage of disease.
View Article and Find Full Text PDFImage-guided percutaneous locoregional therapies for hepatocellular carcinoma.
Chin Clin Oncol
April 2023
Department of Interventional Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Article Synopsis
- * The Barcelona Clinic Liver Cancer (BCLC) staging system, recently updated in 2022, helps guide therapy recommendations, with locoregional therapies advised for early-stage and some intermediate-stage HCC patients.
- * Various image-guided locoregional therapies include multiple forms of ablation and transarterial treatments, with ablation seen as curative, while intra-arterial therapies are generally non-curative, though TARE shows potential as a curative option in specific cases.
Adapting the Utility of Lipiodol CT in Treating Small Hepatocellular Carcinoma.
J Clin Exp Hepatol
July 2021
Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India.
Introduction: Multiphase MRI liver is the gold-standard imaging modality for staging hepatocellular carcinoma (HCC) in patients with cirrhosis. Often, small HCCs diagnosed on multiphase MRI are occult on B-mode ultrasound and multiphase CT (MPCT) and thus pose a challenge for loco-regional therapy. We adapted the technique of lipiodol CT in treating two such patients of small HCC.
View Article and Find Full Text PDF[Local and locoregional treatment of intrahepatic cholangiocarcinoma].
Radiologe
March 2022
Department of Diagnostic and Interventional Radiology, Hannover Medical School, Carl-Neuberg Str. 1, 30625, Hannover, Deutschland.
Clinical/methodical Issue: In the new edition of the German S3-guideline published in June 2021, the diagnosis and treatment of cholangiocarcinoma (CCA) and gallbladder carcinoma are addressed for the first time. This article discusses the local and locoregional treatment options for intrahepatic CCA (iCCA).
Standard Radiological Methods: Mortality is high in iCCA and the incidence is rising.
Early experience of combination therapy of transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma measuring 3-7 cm.
Indian J Radiol Imaging
January 2019
Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.
Background Of The Article: Hepatocellular carcinoma (HCC) is one of the most common human malignancies worldwide. Radiofrequency ablation (RFA) is considered curative option in selected patients; efficacy is severely limited by lesion size and lesions bordering a large vessel. On the other hand, transarterial chemoembolization (TACE) is not limited by lesion size and arterial occlusion of the tumor feeding vessels leads to increase the volume of the ablative zone.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!